Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.

Just over a century ago, in the seemingly post-apocalyptic world of 1918, Van Wyck Brooks famously called for the creation of a new American cultural history that would furnish the nation, and the ...